ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Saving Cell Therapy

MINNEAPOLIS, May 08, 2024 (GLOBE NEWSWIRE) -- NMDPSM (formerly Be The Match®) hosted its annual gala in New York on Thursday, May 2, raising critical funds that support patient financial assistance and innovative cell therapy research to improve post-transplant outcomes and expand access to treatment so every patient can receive their life-saving cell therapy. In 2023, NMDP provided $5.5 million in grants to 2,600 patients and their families in need of financial assistance.

The event, held at Cipriani 25 Broadway, celebrated NMDP’s mission and the impact on 7,435 lives through cell therapy in 2023 for patients battling blood cancers and blood disorders—the most ever facilitated by the organization in a single year. The event’s presenting sponsor, Publicis Groupe and Publicis Media, continued their long-standing support of NMDP.

One of the evening’s biggest highlights was when stem cell transplant recipient Lisa Mottesi, 58, of New Jersey met her life-saving donor, Pennsylvania resident Eric Burger, 50, for the very first time after 16 years. In 2008, the wife and mom of three young children became sick and visited a doctor thinking she had bronchitis only to discover she had an aggressive form of leukemia that doctors said would require a marrow or blood stem cell transplant. Her doctors searched the NMDP Registry and found a single match out of tens of millions of potential donors. Lisa said of meeting her donor, Eric “I would not have seen my children grow up had it not been for him. I am deeply grateful, and words cannot begin to describe the magnitude of his act to save the life of someone he didn’t even know.”

A Media Snippet accompanying this announcement is available by clicking on this link.

“All of us at NMDP are honored to witness meetings like Lisa and Eric’s” said Joy King, Chief Advancement Officer, NMDP. “The funds we’ve raised in New York will bring us closer to achieving our vision—a world where every patient can receive their life-saving cell therapy.”

At the event, NMDP also paid tribute to Academy Award®-nominated and Emmy-winning filmmaker Matthew Heineman, the director of the documentary American Symphony. In collaboration with NMDP, Memorial Sloan Kettering Cancer Center and Higher Ground, Heineman helped launch the American Symphony: Become a Lifesaver campaign late last year. The campaign encouraged more people to join the registry, volunteer and donate funds to help patients and families in need.

NMDP was also proud to recognize AstraZeneca with the 2024 NMDP Corporate Leadership Award for their multi-faceted support of their life-saving mission. AstraZeneca has contributed generously through collaborative and philanthropic initiatives over the past several years. “AstraZeneca is proud to be a long-standing supporter of NMDP’s life-saving work. We encourage everyone to get involved with their important mission—be it through joining the registry, volunteering, or attending an event. Let’s come together to support NMDP and the blood cancer community,” said Nilsa Sanchez, Vice President of Hematology Franchise for U.S. Oncology, AstraZeneca.

Finally, this year’s honorary chairs, Make Me Stronger Foundation, remind us of the importance of connecting with and uplifting the communities we serve. The Make Me Stronger Foundation started by adding thousands of potential donors to the registry in support of their close friend, Sameer Bhatia’s, battle with acute myeloid leukemia. It has since expanded to an inaugural grant of $75,000 that directly aids pre-transplant patients facing financial hardships, ensuring they have access to life-saving blood stem cell transplants. “Knowing all the barriers on a journey to healing, the financial barrier is one we can collectively eliminate and give families more time together," said Ekata Doshi, Make Me Stronger founding member and leukemia warrior.

Thanks in part to fundraising, NMDP has made monumental strides in accelerating progress and expanding access to treatment. The organization recently unveiled breakthrough research that will allow more patients with blood cancer or blood disorders to receive life-saving cell therapy.

About NMDPSM

At NMDPSM, we believe each of us holds the key to curing blood cancers and disorders. As a global nonprofit leader in cell therapy, NMDP creates essential connections between researchers and supporters to inspire action and accelerate innovation to find life-saving cures. With the help of blood stem cell donors from the world’s most diverse registry and our extensive network of transplant partners, physicians and caregivers, we’re expanding access to treatment so that every patient can receive their life-saving cell therapy. NMDP. Find cures. Save lives.

Contact:
Erin Bix
NMDP
917-204-6355
ebix@nmdp.org


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.